0.74 CME

Perkembangan Terbaru dalam Manajemen Hipertensi

Pembicara: Dr. Hesham El-Sayed Gad

Dokter Spesialis Penyakit Dalam di International Modern Hospital, Dubai

Masuk untuk Memulai

Keterangan

When it comes to selecting an agent to treat hypertensive emergencies, clinical practice varies.A standardized pharmacotherapeutic approach would be suggested based on evidence from the published literature when national guidelines are developed.In the treatment of hypertensive emergencies, such an approach might reduce variation among practitioners and institutions.There are benefits and drawbacks to every treatment option for hypertensive emergencies.With a variety of short-acting intravenous agents available, clinicians must educate themselves about which medication is best for their patients. These decisions should be based on the patient's clinical presentation as well as organ function.In hypertensive emergencies, the primary objective is to stop further end-organ damage by reducing blood pressure quickly and safely.When it comes to providing these patients with safe and efficient care, critical care nurses play a crucial role.For hypertensive emergencies, using knowledge of treatment goals, hemodynamic monitoring, and pharmacological treatment can help these critically ill patients recover safely.

Ringkasan

  • The presentation discusses hypertension, emphasizing its prevalence, impact on lifestyle, and rising rates globally. It notes that hypertension can affect individuals without a prior history and highlights the need for detailed information and management strategies. Data on hypertension rates in various regions like America and Africa are presented.
  • The discussion delves into treatment approaches for hypertension, focusing on medication and the importance of evaluating treatment adherence. It mentions the significance of patient education and support in managing hypertension effectively. Specific medications and their applications, including beta-blockers, are discussed.
  • The presenter explores various factors impacting hypertension, including lifestyle, biological considerations, and patient-specific needs. They emphasize that treatment should be personalized and never be a one-size-fits-all approach. The presentation includes data and comparisons related to medication effectiveness.
  • The presentation continues to investigate data on hypertension and related conditions such as diabetes. Comparative data are provided between primary and secondary cases, as well as different patient profiles. These comparisons involve various treatment options and the number of affected individuals in treatment groups.

Komentar